Corrected QT-interval in non-ST segment elevation acute coronary syndrome: prognostic implications at long term

被引：0
|
作者：
Jimenez-Candil, J.
Cruz, I.
Gonzalez, J. M.
Martin, F.
Pabon, P.
Luengo, C. Martin
机构：
来源：
EUROPEAN HEART JOURNAL | 2006年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：350 / 350
页数：1
相关论文
共 50 条
  • [31] Non-ST segment elevation acute coronary syndromes: A comprehensive review
    Martinez-Rumayor, Abelardo
    Januzzi, James L., Jr.
    SOUTHERN MEDICAL JOURNAL, 2006, 99 (10) : 1103 - 1110
  • [32] Short- and Long-Term Prognostic Significance of ST-Segment Elevation in Lead aVR in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome
    Taglieri, Nevio
    Marzocchi, Antonio
    Saia, Francesco
    Marrozzini, Cinzia
    Palmerini, Tullio
    Ortolani, Paolo
    Cinti, Laura
    Rosmini, Stefania
    Vagnarelli, Fabio
    Alessi, Laura
    Villani, Caterina
    Scaramuzzino, Giuseppe
    Gallelli, Ilaria
    Melandri, Giovanni
    Branzi, Angelo
    Rapezzi, Claudio
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 108 (01): : 21 - 28
  • [33] Diabetes mellitus in patients with non-ST segment elevation acute coronary syndrome - worse prognosis?
    Sousa, P.
    Marques, N.
    Chin, J.
    Silva, J.
    Amado, J.
    Santos, W.
    Lopes, A.
    Pina, E.
    Mimoso, J.
    Pereira, S.
    Brandao, V.
    Jesus, I.
    DIABETOLOGIA, 2012, 55 : S30 - S30
  • [34] Dysaggregants effect of platelet aggregation in patients with non-ST segment elevation acute coronary syndrome
    Poponina, TM
    Kapilevich, NA
    Kisteneva, TV
    Markov, VA
    Novitsky, VV
    TERAPEVTICHESKII ARKHIV, 2004, 76 (08) : 18 - 22
  • [35] Tirofiban and eptifibatide treatment of patients presenting with acute coronary syndrome with non-ST segment elevation
    Corominas, N
    Perez, J
    Ortiz, J
    Ferrer, E
    Ribas, J
    Sanz, G
    PHARMACY WORLD & SCIENCE, 2004, 26 (01): : 38 - 43
  • [36] Tirofiban and eptifibatide treatment of patients presenting with acute coronary syndrome with non-ST segment elevation
    Nuria Corominas
    Josep Ribas
    Joaquin Perez
    Jose Ortiz
    Elena Ferrer
    Gines Sanz
    Pharmacy World and Science, 2004, 26 : 38 - 43
  • [37] Immediate, mediate and late invasive strategy in non-ST segment elevation acute coronary syndrome
    Caraballoso Garcia, Liliete
    Caraballoso Garcia, Victor J.
    Orea Cordero, Idanis
    Solis de la Paz, Dayma
    CORSALUD, 2018, 10 (03): : 192 - 201
  • [38] A study of IgG antibodies to the ApoB protein in non-ST segment elevation acute coronary syndrome
    Zhang, Xueying
    Yu, Bo
    Jin, Yuanzhe
    Lei, Mingming
    Zhang, Xiaohong
    Duan, Zhiying
    Lin, Yingzi
    Megson, Ian L.
    Wei, Jun
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2015, 49 (03) : 136 - 141
  • [39] The recommendations regarding non-ST segment elevation acute coronary syndrome have been reviewed
    Civeira Murillo, E.
    Del Nogal Saez, F.
    Alvarez Ruiz, A. P.
    Ferrero Zorita, J.
    Alcantara, A. G.
    Aguado, G. H.
    Lopez Messa, J. B.
    Monton Rodriguez, J. A.
    MEDICINA INTENSIVA, 2010, 34 (01) : 22 - 45
  • [40] Functional mitral regurgitation after a Non-ST segment elevation acute coronary syndrome contributes to long-term atrial fibrillation development
    Nunez-Gil, I.
    Zamorano, J.
    Perez De Isla, L.
    Fernandez-Golfin, C.
    Marcos-Alberca, P.
    Almeria, C.
    Rodrigo, J. L.
    Herrera, D.
    Aubele, A.
    Macaya, C.
    EUROPEAN HEART JOURNAL, 2009, 30 : 701 - 701
12345